The peptide protocol described above is prescribed by me, sourced through a US cGMP-certified compounding pharmacy, dosed for the patient and the procedure, and integrated into a recovery plan I have built operating on local, national, and international patients for the last fifteen years
Bioglutide (NA-931) Phase 2: 13.8% Oral Weight Loss The Phase 2 trial reported oral quadruple agonist NA-931 hit 13.8% weight loss with no muscle loss
Today 14 , 162167
(PubMed) Moshfegh A, Goldman J, Cleveland L
Significance between groups is indicated with different symbols
Grzeszczak, K., Lanocha-Arendarczyk, N., Malinowski, W., Zietek, P